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Expression Profiling of UVB Response in Melanocytes
Identifies a Set of p53-Target Genes
Guang Yang1, Guoqi Zhang1, Mark R. Pittelkow2, Marco Ramoni3 and Hensin Tsao1,4,5
Epidermal melanocytes execute specific physiological programs in response to UV radiation (UVR) at the
cutaneous interface. Many melanocytic responses, including increased dendrite formation, enhanced
melanogenesis/melanization, and cell cycle arrest impact the ability of melanocytes to survive and to attenuate
the UVR insult. Although some of the molecules that underlie these UVR programs are known, a coherent
view of UVR-induced transcriptional changes is lacking. Using primary melanocyte cultures, we assessed for
UVR-mediated alterations in over 47,000 transcripts using Affymetrix Human Genome U133 Plus 2.0 microarrays.
From the 100 most statistically robust changes in transcript level, there were 84 genes that were suppressed
42.0-fold by UVR; among these transcripts, the identities of 48 of these genes were known. Similarly, there were
99 genes that were induced 42.0-fold by UVR; the identity of 57 of these genes were known. We then subjected
these top 100 changes to the Ingenuity Pathway analysis program and identified a group of p53 targets
including the cell cycle regulator CDKN1A (p21CIP), the WNT pathway regulator DKK1 (dickkopf homolog 1),
the receptor tyrosine kinase EPHA2, growth factor GDF15, ferrodoxin reductase (FDXR), p53-inducible protein
TP53I3, transcription factor ATF3, DNA repair enzyme DDB2, and the b-adrenergic receptor ADBR2. These genes
were also found to be consistently elevated by UVR in six independent melanocyte lines, although there were
interindividual variations in magnitude. WWOX, whose protein product interacts and regulates p53 and p73,
was found to be consistently suppressed by UVR. There was also a subgroup of neurite/axonal developmental
genes that were altered in response to UVR, suggesting that melanocytic and neuronal arborization may share
similar mechanisms. When compared to melanomas, the basal levels of many of these p53-responsive genes
were greatly dysregulated. Three genes – CDKN1A, DDB2 and ADRB2 – exhibited a trend towards loss of
expression in melanomas thereby raising the possibility of a linked role in tumorigenesis. These expression data
provide a global view of UVR-induced changes in melanocytes and, more importantly, generate novel
hypotheses regarding melanocyte physiology.
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INTRODUCTION
Epidermal melanocytes, which comprise about 10% of
all epidermal cells, function as the guardian against
excessive UV radiation (UVR) damage to the skin. Although
the epidermis may thicken with chronic UVR exposure,
the melanocyte undergoes critical physiological changes –
such as increased dendrite formation, melanogenesis, and
melanosome translocation – that is responsible for attenuating
much of the deleterious effects of UVR (Walker et al., 2003).
The importance of an adequate melanin ‘‘shield’’ to
minimize UVR chronic damage has been further reinforced
by more recent discoveries that genetic determinants of
pigmentation dictate skin cancer risk (Rees, 2003).
Constitutive pigmentation (i.e. skin color), over the course
of evolution, and facultative pigmentation (i.e. tanning), over
the course of physiological response, comprise the spectrum
of pigmentary responses to UVR controlled by melanocytes.
In vivo, there is an inverse relationship between level of
constitutive pigmentation and amount of in situ photopro-
ducts after UV irradiation; moreover, melanin content in the
skin increases to a greater extent in individuals with darker
skin (Tadokoro et al., 2003). Similar results have been found
in culture where more heavily pigmented melanocytes
appear to better stimulate melanogenesis in response to
UVR and are more resistant to the toxic effects of UVR
(Friedmann and Gilchrest, 1987; Barker et al., 1995).
Kobayashi et al. (1993) also documented in culture that
melanoma cells with greater melanization harbored fewer
photoproducts after UVB exposure. Melanocytes appear to be
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less sensitive to UVR-induced cytotoxicity than keratinocytes
in all three UV spectra (de Leeuw et al., 1994).
Studies of UVR responses at the molecular level has
advanced most quickly using primary melanocyte cultures
and more readily cultivated melanoma cells. UVR exposure
induces a G1 arrest in melanocytes that is at least partially
attributable to both p53 (Barker et al., 1995) and p16INK4a
(Pavey et al., 1999). This cell cycle arrest is essential
for effective removal of potentially mutagenic photoproducts,
a repair mechanism termed nucleotide excision repair
(Aboussekhra et al., 1995; Lehmann, 1995; Bootsma et al.,
1998). Studies of patients with defects in nucleotide excision
repair (i.e. xeroderma pigmentosum) suggest that this
genomic caretaker function is critical in maintaining genetic
homeostasis within melanocytes as individuals with xero-
derma pigmentosum exhibit a 600–8,000-fold increase in the
rate of melanoma (Kraemer et al., 1994).
Melanocyte survival after UVR exposure also reflects a
complex balance between apoptotic and antiapoptotic
programs. Upon UVB irradiation, cultured human melano-
cytes can undergo apoptosis in a dose-dependent manner
(Kadekaro et al., 2003). Although the apoptotic response
may, in part, result from increased p53 levels (Barker et al.,
1995), there is also evidence of mitochondrial participation
as Bax levels increase and Bcl-2 levels decrease after UVR
exposure (Im et al., 1998; Kadekaro et al., 2003). Bcl-2 itself
plays an essential role in melanocyte maintenance as
mice deficient for BCL2 undergo loss of follicular melano-
cytes (Veis et al., 1993). There are also several survival
inputs that antagonize these apoptotic responses. Irradia-
tion of melanocytes with UVR leads to activation of the
Akt pathway, which in turn, results in phosphorylation and
inhibition of the proapoptotic functions of Bad (del
Peso et al., 1997; Kadekaro et al., 2003). In addition, UVR
exposure induces phosphorylation of cAMP response
element binding protein through activation of mitogen-
activated protein kinase p38 (Tada et al., 2002). One of
the targets of cAMP response element binding protein is
Mitf, a transcription factor known to enhance melanocyte
survival through increased expression of Bcl-2 (McGill
et al., 2002).
Local paracrine and possibly autocrine circuits also
regulate melanocyte function in response to UVR. For
instance, keratinocytes, when exposed to UVR, have been
shown to elaborate a-melanocyte stimulating hormone
(MSH) and endothelin 1 (Yohn et al., 1993; Chakraborty
et al., 1996), both of which can stimulate melanogenesis
(Abdel-Malek et al., 1995; Tada et al., 1998) and drive
melanocytes to overcome the UV-induced G1 arrest (Im
et al., 1998; Tada et al., 1998). In addition to melanocyte
proliferation, endothelin 1 of keratinocyte origin also
promotes melanocyte dendricity in response to UV irradia-
tion (Hara et al., 1995).
Many molecules have been shown to be induced by
UVR specifically in melanocytes (Hu et al., 1997; Bulavin
et al., 1999; Huang et al., 1999; Tibbetts et al., 1999; Lefort
et al., 2001; Chouinard et al., 2002; McGill et al., 2002;
Tada et al., 2002; Kadekaro et al., 2003; Zhang and Rosdahl,
2003; Wang et al., 2004). The response network is quite rich
with signaling kinases (Atr, Jnk, p38, Akt), transcription
factors (Id1, N-oct3, p73, p53, cAMP response element
binding protein, Mitf) and target effectors for cell cycle
regulation (p16INK4a, Gadd45, p21CIP), DNA repair
(Gadd45, Ddb2) and survival (Bax, Bcl-2). Interactions
among these known and yet-to-be discovered components
refine and define a patterned set of responses on the cell
cycle, genomic repair, and apoptosis/survival. Furthermore,
mutations, altered expression, or activation of many of these
molecules and pathways (e.g. p16INK4a, p53, Ddb2, Mitf,
Bcl-2, Akt) have been shown to play roles in the pathogenesis
of melanoma. Along these lines, an inherited polymorphism
in TP53 (Arg72Pro) has been reported to dictate melanoma
risk (Shen et al., 2003); individual variation in the capacity of
p53 to induce downstream targets may, in part, explain this
observation. Thus, the impact of perturbations on these early
UVR response modifiers may lead to more enduring and
carcinogenic outcomes over time.
Although much of understanding of UVR responses in
melanocytes are based on single-gene/pathway approaches,
Valery et al. (2001) undertook a 9,000-transcript human
cDNA microarray approach to study UVR in melanocytes at
the transcriptome level. These investigators selected a
polygenic (pooled) melanocyte population from several
individuals and analyzed changes at 4 hours post-irradiation.
Overall, 198 out of 9,000 genes were shown to be altered
(41.9-fold) with 117 clones and 81 clones suppressed and
induced by UVR, respectively (Valery et al., 2001). Although
this study represents an early attempt at a systematic
classification of UVR-response genes in melanocytes, the
restricted number of genes interrogated and the narrow
dynamic range (induction ranged from 1.9- to 2.6-fold) limit
the generalizability of these results.
With the availability of much higher density microarrays,
a more thorough annotation of the human genome
and a stronger technical and technological platform to
analyze expression data, we set out to undertake a global
view of UVR-response gene expression in order to
generate novel hypotheses regarding melanocyte physio-
logy in the context of its major epidermal function-UVR
attenuation.
In contrast to the previous microarray study (Valery et al.,
2001), we (1) utilized the Affymetrix Human Genome U133
Plus 2.0 Chips, which interrogate approximately 47,000
transcripts, (2) used a monogenic approach, and (3) selected
a 24-hour time point of analysis in order to enrich for more
downstream effectors post-immediate early-gene responses.
Using the Ingenuitys Pathway Analysis program, we
identified a group of p53 targets that appears to be selectively
induced by UVR. In an independent panel of primary
melanocytes, these genes were all found to be consistently
increased by UVR, although the levels of induction varied
by individual. As p53 loss, either through direct mutagenesis
or ARF inactivation (Yang et al., 2005), plays a central role
in melanoma pathogenesis, we also examined the levels of
these genes in melanoma cell lines relative to primary
melanocytes.
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RESULTS
Microarray results
An overall representation of the results is presented as a
‘‘volcano’’ plot in Figure 1. To prioritize these changes, we
used GeneCluster 2.0 to rank the top 100 most-suppressed
(Figure 2) and top 100 most-induced (Figure 3) genes by their
statistical significance (from highest (top) to lowest (bottom)).
Subsequent annotation of these transcripts revealed 84 genes
that were suppressed 42.0-fold by UVR; among these
transcripts, the identities of 48 of these genes are known
and listed in the Table 1 (sorted by fold-suppressed).
Similarly, there were 99 genes that were induced 42.0-fold
by UVR; the identity of 57 of these genes are known and
enumerated in Table 2 (sorted by fold-induced).
Ingenuity pathway analysis
In order to derive a more coherent view of the microarray
changes, we then subjected the top 100 most-induced and
most-suppressed genes to the Ingenuitys Pathway Analysis
software package. The largest cluster of transcriptional
activity was found to be related to p53 (Table 3), whose
activity is known to be stimulated by UVR by post-
transcriptional mechanisms. The genes IER3 (also known as
IEX-1, DIF-2, PRG1, IEX-1L), a Myc target, and NR4A1 (also
known as TR3, N10, NAK-1, NGFIB, NUR77), an Egr-1
target, were also identified. We thus focused our validation
efforts on this list of genes culled from the Ingenuity database
(Table 3 – designated UVR clusters, or UVRc).
Individual variation in UVRc response
We then examined possible variations in UVR response
among the UVRc genes by singly irradiating (35 and 50 mJ/
cm2) a panel of six primary melanocyte cultures and assessing
for gene expression differences through quantitative PCR. As
shown in Figure 4, there are indeed individual variations in
response to UVR. In general, the UVR induction was more
robust with 50 than 35 mJ/cm2. There were some cell lines
(such as line normal human melanocyte (NHM) No. 5)
that were generally more responsive than other lines.
However, all of the lines showed 42-fold induction for
most, if not all of the genes. Likewise, all of the genes
exhibited UVR-induction in at least one cell line. WWOX
appeared on the Ingenuity search because the protein
product interacts with p53 (Chang, 2002; Chang et al.,
2003) but is not necessarily a transcriptional target. This gene
is consistently reduced by UVR exposure in melanocytes, a
phenomenon that has been reported only in cancer cell lines
(Chang et al., 2005).
Other expression changes
Using Gene Ontology designations and the published
literature, we were able to assign some functional attributes
to some of the annotated suppressed and induced genes
(Table 4). These have been classified by their involvement,
including neuronal/axonal guidance and development,
apoptosis, protein/vesicular transport, DNA/RNA modifica-
tion, cell cycle, metabolism, redox regulation/steroid
metabolism and angiogenesis. We have also grouped all
the known transcription factors. It is clear that some genes
participate in multiple processes and are thus classified into
several groups.
Bcl-2 is known to be induced by UVR (Kadekaro et al.,
2003). We thus interrogated our microarray for entire BH
family of proteins including prosurvival members Bcl-2,
Bcl-XL, A1, Bcl-w, and Mcl-1 and proapoptotic members
Bax, Bad, Bok, Bid, Bim, Bik, Hrk, Noxa, and Puma (Cory
and Adams, 2002). Overall, there was a general trend for
these genes to be elevated in UVR-exposed cells, although
most of these changes were not statistically significant
(Figure 5; Supplementary Table S1).
Similarly, we examined genes known to be involved in
pigmentation either through biochemistry or genetics by
mutations affecting the pigmentary phenotype. These genes,
including melanocortin-1-receptor (MC1R), tyrosinase (TYR),
tyrosinase-related protein 1 (TYRP1), dopachrome tautomer-
ase (DCT), pink-eye dilution homolog (OCA2), lysosomal
trafficking regulator (LYST), solute carrier family 24, member
5 (SLC24A5), myosin 5a (MYO5A), Rab27a (RAB27A),
melanophilin (MLPH), Hermansky-Pudlak 1, 3, 4,5 (HPS1,
HPS3, HPS4, HPS5), c-kit (KIT), Pax3 (PAX3), Mitf (MITF),
endothelin receptor B (EDNRB), endothelin 3 (EDN3), and
SRY (sex determining region Y)-box 10 (SOX10), did not
exhibit any consistent or significant patterns of response to
UVR (Supplementary Table S2).
Relative expression in melanoma cell lines
Many of the UVRc genes have already been implicated
in human oncogenesis including ATF3 (Pelzer et al., 2006),
CDKN1A (p21CIP) (Gartel and Radhakrishnan, 2005),
GDF15 (Cheung et al., 2004), EPHA2 (Kinch and Carles-
Kinch, 2003), WWOX (Iliopoulos et al., 2006), DDB2 (Yoon
et al., 2005), FDXR (Hwang et al., 2001), NR4A1 (Li et al.,
2006), and DKK1 (Gonzalez-Sancho et al., 2005). This raises
the possibility that the UVRc genes may also participate
in melanoma tumorigenesis. To this end, we evaluated
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Figure 1. Volcano plot of transcriptional response to UV radiation. The
X-axis represents the relative fold change by UVR transformed by log2, that is,
unchanged by UVR¼0. The Y-axis is the significance of the change by T-test
P-value transformed by log10. The two lines represent 2-fold induction and
suppression by UVR – a cutoff used in our analysis.
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the relative basal levels of these genes in four primary
melanocyte lines (Figure 6: NHM-3 and 5 (lanes 1, 2) from
the University of Vermont, NHM-5 (lane 3) from Clonetics,
and NHM-6 (lane 4) from Mayo Clinic) vis-a`-vis a panel of six
melanoma cells lines (Figure 6: UACC903, A375, WM164,
SK-Mel-28, WM35, and MM-LH in lanes 5, 6, 7, 8, 9, and 10,
respectively). In all samples, we normalized the levels of
these genes to endogenous b-glucuronidase, which remained
Control UV
Gb:AW274503
B1-parathyroid harmone-responsive B1 gene
LILRA2-leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2
Gb:AI800713
AURKB-aurora kinase B
NLGN-neuroligin 1
Gb:BF968243
Gb:AK024621.1
WWOX-WW domain containing oxidoreductase
TPK1-thiamin pyrophosphokinase 1
Gb:AK000115.1
Gb:AL353746
Gb:AW291402
Gb:AB028966.1
CNTN4-contactin 4
DPYD-dihydropyrimidine dehydrogenase
CNGB1-cyclic nucleotide gated channel beta 1
GLS-glutaminase
Gb:Au146864
KCNK3-potassium channel, subfamily K, member 3
ZNF291-zinc finger protein 291
RABGAP1L-RAB GTPase activating protein 1-like
POU3F1-POU domain, class 3, transcription factor 1
DCDC2-doublecortin domain containing 2
Gb:AW16772
Gb:AI435595
Gb:AF267860.1
Gb:AL136607.1
Gb:AK024568.1
Gb:H16409
GPHN-gephyrin
Gb:NM_023037.1
Gb:BC038746.1
Gb:AL355688.1
Gb:AL389983.1
Gb:AK026748.1
ITGA2B-integrin, alpha 2b
CSRP2BP-CSRP2 binding protein
BCAP29-B-cell receptor-associated protein 29
Gb:BF109461
Gb:AU154991
Gb:NM_014152.1
MRPL49- mitochondrial ribosomal protein L49
Gb:AK025009.1
Gb:AK097655.1
Gb:AA058834
Gb:AK098098.1
Gb:BE393431
Gb:AI217900
SYNE2-spectrin repeat containing, nuclear envelope 2
COH1-Cohen syndrome 1
TFCP2L1- transcription factor CP2-like 1
STIM1- stromal interaction molecule 1
JMJD2B- Jumonji domain containing 2B
KIF27- kinesin family member 27
Gb:U95737
RNASE-ribonuclease, RNase A family, 7
NAP5-Nck-associated protein 5
ENPEP-glutamyl aminopeptidase (aminopeptidase A)
Gb:NM_018607.3
Gb:AJ300461.1
Gb:N31985
Gb:AL050097.1
Gb:U55983
Gb:AB051486.1
Gb:AI979276
Gb:AV657587
Gb:BC033368.1
Gb:BF939798
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CNTN3-contactin 3 (plasmacytoma assciated)
MGMT-O-6-methylguanine-DNA methyltransferase
CAMK1D-calcium/calmodulin-dependent protein kinase ID
WFIKKNRP-WFIKKN-related protein
TBC1D5- TBC1 domain family, member 5
LRCH3- leucine rich repeats and calponin homology (CH) containing 3
AKAP28-A-kinase anchoring protein 28
CILP2-cartilage intermediate layer protein 2
ZAN-zonadhesin
LRBA-LPS-responsive vesicle trafficking, beach and anchor containing
DIAPH2-diaphanous homolog 2 (Drosophila)
SLC22A3-solute carrier family 22 (extraneuronal monoamine transporter), member 3
ZFP91-zinc finger protein 91 homolog
HMGN2-high-mobility group nucleosomal binding domain 2
SHOX2-short stature homeobox 2
SEC15L2-SEC15-like 2 (S. cerevisiae)
SCDF2- sec1 family domain containing 2
LAMA2-laminin, alpha 2 (merosin, congenital muscular dystrophy
PRKG1-protein kinase, cGMP-dependent, type I
GMDS-GDP-mannose 4,6-dehydratase GDP-mannose 4,6-dehydratase
SMYD3- SET and MYND domain containing 3
C1GALT1-core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta
WWOX-WW domain containing oxidoreductase
EGLN3- egl nine homolog 3 (C. elegans)
MSRA-methionine sulfoxide reductase A
ALS2CR19-amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 19
ROBO2-roundabout, axon guidance receptor, homolog 2 (Drosophila)
ANK3-ankyrin 3, node of Ranvier (ankyrin G)
HDAC6-histone deacetylase 6
PPM1L-protein phosphatase 1 (formerly 2C)-like
Figure 2. Top 100 genes suppressed by UVR ranked by P-value. This is a heat map showing the most significant (top) to least significant (bottom) predictors. The
P-values were derived from the corrected T-statistic as outlined in Golub et al. (1999).
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relatively constant through the various experiments (mean
CT¼25.1270.85 after 360 independent assays).
We assumed, on genetic grounds, that canonical onco-
genic and tumor suppressor genes would exhibit over-
expression and loss of expression, respectively. Although
the number of samples examined were small, in aggregate,
CDKN1A (P¼ 0.10, two-tailed t-test), b-2 adrenergic receptor
(ADRB2; P¼0.093, two-tailed t-test), and DNA damage
Control UV
NM_025089.1
SEC31L1- sec31-like 1
CYP3A7- cytochrome P450, family 3, subfamily A, polypeptide 7
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FBX032- F-box protein 32
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RPS6KA6- ribosomal protein S6 kinase A6
Gb:BC015135.1
FDXR- ferrodoxin reductase
TCEA3- transcription elongation factor A (S11), 3
NFIX- nuclear factor I/X (CCAAT-binding transcription factor)
IGSF4-immunoglobulin superfamily, member 4
MGC23401
Gb:AI190575
DKK1- dickkopf homolog 1 (Xenopus laevis)
Gb:AU157313
STX7- syntaxin 7
Gb:AC004381
CDA08
GPLD1- glycosylphosphatidylinositol specific phospholipase D1
ONECUT1-one cut domain, family member 1
Gb:AF070587.1
PAPLN- papillin
FLRT2- fibronectin like domain-containing leucine-rich transmembrane protein 2
ARHGEF12- Rho guanine nucleotide exchange factor (GEF) 12
F12- Factor XII
SNCAIP- synphilin 1
ANAPC11-APC11 anaphase promoting complex subunit 11 homolog (yeast)
IER3- immediate early response 3
Gb:NM_024751.1
ATP6VOD2- ATPase, H+ transporting, lysosomal 38kDa, V0 subunit disoform 2
WFDC6- WAP four-disulfide core domain 6
Gb:AI808830
pyruvate dehydrogenase kinase 4
Gb:AK025072.1
DDB2- damage specific DNA binding protein 2
GPR115- G protein-coupled receptor 115
LIPH- lipase, member H
ARHGAP23- Rho GTPase activating protein 23
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Gb:AK094730.1
Gb:AF309700.1
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UNC B-unc-5 homolog B (C. elegans)
CDH26- cadherin like 26
Gb:AW469714
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BAT1- HLA-B associated transcript 1
RAB40B
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NR4A1- nuclear receptor subfamily 4, group A, member 1
PLEKHA6- pleckstrin homology domain containing, family A member 6
NSUN4- NOL1/NOP2/Sun domain family, member 4
Gb:AW269970
PBEF- pre-B-cell colony enhancing factor 1
Gb:AA815055
ADRB2- adrenegic, beta-2, receptor
AF5Q31- ALL1 fused gene from 5q31
STS-1- CbI-interacting protein Sts-1
Gb:AI080505
TRIM55- tripartite motif-containing 55
Gb:N30008
Gb:ALI990151
RBPMS- RNA binding protein with multiple splicing
NYD-SP29- testis development protein NYD-SP29
GPR55- G protein-coupled receptor 55
KRTAP4.5- keratin associated protein 4.5
Gb:AW300612
TP53I3- quinone oxidoreductase
Gb:BF678298
FLJ12242
ATF3- activating transcription factor 3
Gb:AL008627
BRUNOL4-bruno-like 4, RNA binding protein (Drosophila)
Gb:AA625583
CSPG2- chondroitin sulfate proteoglycan 2 (versican)
CDKN1A- cyclin dependent kinase inhibitor 1A
Gb:AW072559
Gb:BC038725.1
Gb:AW444673
AKR1C4-aIdo-keto reductase family 1, member C4
MCOLN1
MYO1F- myosin 1F
Gb:AW451432
Gb:AW340987
Gb:AI821779
AGGF1- angiogenic factor with G patch and FHA domains 1
PLGL- plasminogen-like
GDF-15- growth differentiation factor 15
Gb:BF515755
Gb:AW295105
ZNF-175-zinc finger protein 175
Gb:AI393479
Figure 3. Top 100 genes induced by UVR ranked by P-value. This is a heat map showing the most significant (top) to least significant (bottom) predictors. The
P-values were derived from the corrected T-statistic as outlined in Golub et al. (1999).
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Table 1. Top 100 T-statistic ranked annotated genes (UVR-suppressed)
Fold suppression P-value Gene Description
7.32 0.0003 B1 Parathyroid hormone-responsive B1 gene
6.52 0.0064 CNTN4 Contactin 4
6.33 0.0084 GLS gGlutaminase
5.59 0.0079 CNGB1 Cyclic nucleotide gated channel beta 1
5.32 0.0292 LRCH3 Leucine-rich repeats and calponin homology (CH) domain containing 3
4.97 0.0273 JMJD2B Jumonji domain containing 2B
4.77 0.005 HDAC6 Histone deacetylase 6
4.77 0.0021 AURKB Aurora kinase B
4.69 0.0288 NAP5 Nck-associated protein 5
4.35 0.027 SYNE2 Spectrin repeat containing, nuclear envelope 2
4.25 0.0273 TFCP2L1 Transcription factor CP2-like 1
4.18 0.0149 PRKG1 Protein kinase, cGMP-dependent, type I
4.01 0.0092 KCNK3 Potassium channel, subfamily K, member 3
3.97 0.0095 DCDC2 Doublecortin domain containing 2
3.94 0.0056 ROBO2 Roundabout, axon guidance receptor, homolog 2 (Drosophila)
3.76 0.0296 ENPEP Glutamyl aminopeptidase (aminopeptidase A)
3.74 0.0277 KIF27 Kinesin family member 27
3.71 0.0342 CAMK1D Calcium/calmodulin-dependent protein kinase ID
3.56 0.0008 LILRA2 Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2
3.28 0.0162 GMDS GDP-mannose 4,6-dehydratase
3.27 0.0034 WWOX WW domain containing oxidoreductase
3.16 0.0219 CSRP2BP CSRP2 binding protein
3.06 0.0093 RABGAP1L RAB GTPase activating protein 1-like
2.99 0.0076 DPYD Dihydropyrimidine dehydrogenase
2.89 0.0273 STIM1 Stromal interaction molecule 1
2.86 0.0337 CNTN3 Contactin 3 (plasmacytoma associated)
2.76 0.0116 C1GALT1 Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta
2.65 0.0198 SLC22A3 Solute carrier family 22 (extraneuronal monoamine transporter), member 3
2.65 0.0237 MRPL49 Mitochondrial ribosomal protein L49
2.62 0.0031 NLGN1 Neuroligin 1
2.62 0.005 ANK3 Ankyrin 3
2.54 0.0219 ITGA2B Integrin, alpha 2b
2.47 0.0112 EGLN3 egl nine homolog 3 (C. elegans)
2.46 0.0111 WWOX WW domain containing oxidoreductase
2.45 0.0102 ALS2CR19 Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 19
2.42 0.0175 HMGN2 High-mobility group nucleosomal binding domain 2
2.41 0.0208 DIAPH2 Diaphanous homolog 2 (Drosophila)
2.35 0.0094 POU3F1 POU domain, class 3, transcription factor 1
2.34 0.0228 CILP2 Cartilage intermediate layer protein 2
2.34 0.0099 MSRA Methionine sulfoxide reductase A
2.32 0.0114 SMYD3 SET and MYND domain containing 3
2.24 0.0141 LAMA2 Laminin, alpha 2 (merosin, congenital muscular dystrophy
2.18 0.0054 PPM1L Protein phosphatase 1 (formerly 2C)-like
2.16 0.0243 AKAP28 A kinase (PRKA) anchor protein 14
2.15 0.0136 SEC15L2 SEC15-like 2 (S. cerevisiae)
2.11 0.0288 RNASE7 Ribonuclease, RNase A family, 7
2.10 0.0337 MGMT O-6-methylguanine-DNA methyltransferase
2.06 0.0035 TPK1 Thiamin pyrophosphokinase 1
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Table 2. Top 100 T-statistic ranked annotated genes (UVR-Induced)
Fold induction P-value Gene Description
8.01 0.0007 FBXO32 F-box protein 32
6.52 0.0003 CYP3A7 Cytochrome P450, family 3, subfamily A, polypeptide 7
5.54 0.0057 TRIM55 Tripartite motif-containing 55
5.54 0.0002 SEC31L1 SEC31-like 1
5.43 0.0046 CYP3A5 Cytochrome P450, family 3, subfamily A, polypeptide 5
4.66 0.0055 RBPMS RNA binding protein with multiple splicing
4.55 0.0007 RAB25 RAB25, member RAS oncogene family
4.51 0.0016 IGSF4 Immunoglobulin superfamily, member 4
4.46 0.0029 MYO1F Myosin 1F
4.43 0.0039 GPR115 G protein-coupled receptor 115
4.39 0.0024 ONECUT1 Onecut domain, family member 1
4.3 0.0051 NSUN4 NOL1/NOP2/Sun domain family, member 4
4.15 0.0038 ATP6VOD2 ATPase, H+ transporting, lysosomal 38 kDa, V0 subunit d isoform 2
4.12 0.0013 ZNF-175 Zinc-finger protein 175
4.07 0.005 NR4A1 Nuclear receptor subfamily 4, group A, member 1
4.06 0.0009 PITPNB Phosphatidylinositol transfer protein
4.03 0.0005 EPHA2 EPH receptor A2
3.97 0.0021 PLGL Plasminogen-like
3.93 0.0009 CENTA1 CENTA1-centaurin, alpha 1
3.83 0.0049 BAT1 HLA-B associated transcript 1
3.81 0.0043 ARHGAP23 Rho GTPase activating protein 23
3.58 0.0037 BRUNOL4 Bruno-like 4, RNA binding protein (Drosophila)
3.55 0.0028 AKR1C4 Aldo-keto reductase family 1, member C4
3.46 0.0054 AF5Q31 ALL1 fused gene from 5q31
3.27 0.0047 UNC5B unc-5 homolog B (C. elegans)
3.16 0.0036 ANAPC11 APC11 anaphase promoting complex subunit 11 homolog (yeast)
3.1 0.0038 WFDC6 WAP four-disulfide core domain 6
3.03 0.0016 NFIX Nuclear factor I/X (CCAAT-binding transcription factor)
3.01 0.002 STX7 Syntaxin 7
3.01 0.0033 ARHGEF12 Rho guanine nucleotide exchange factor (GEF) 12
3.01 0.0034 F12 Factor XII (Hagemann factor)
2.99 0.0014 RPS6KA6 Ribosomal protein S6 kinase A6
2.97 0.0022 GPLD1 Glycosylphosphatidylinositol specific phospholipase D1
2.8 0.0054 ADRB2 Adrenergic, beta-2-, receptor, surface
2.78 0.0017 DKK1 Dickkopf homolog 1 (Xenopus laevis)
2.77 0.0041 LIPH Lipase, member H
2.72 0.0053 KRTAP4.5 Keratin-associated protein 4, 5
2.6 0.0032 FLRT2 Fibronectin-like domain-containing leucine rich transmembrane protein 2
2.58 0.0035 SNCAIP Synuclein, alpha interacting protein (synphilin)
2.57 0.0024 AGGF1 Angiogenic factor with G patch and FHA domains 1
2.5 0.0051 PLEKHA6 Pleckstrin homology domain containing, family A member 6
2.49 0.0056 GPR55 G protein-coupled receptor 55
2.47 0.0015 FDXR Ferredoxin reductase
2.44 0.0016 TCEA3 Transcription elongation factor A (SII), 3
Table 2 continued on following page
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binding protein 2 (DDB2; P¼0.049, two-tailed t-test)
showed a tendency towards expression loss in melanomas
when compared to melanocytes. Dickkopf homolog 1
(DKK1) exhibited a trend towards expression loss except in
a single melanoma cell line (SK-Mel-28). EPHA2 was strongly
elevated in some melanoma cell lines whereas all of the
melanocytes showed relatively low levels consonant with
prior reports (Seftor et al., 2002).
Overall, the variation observed among melanocyte lines
also seemed more blunted than among melanoma cell lines.
Across all genes examined, the mean coefficients of variation
for the melanocyte lines and melanoma cell lines were 44.4
and 104.3, respectively (P¼ 0.00073). This suggests that the
genes may be under tighter regulation in primary cells but
they become dysregulated, either through genetic or epige-
netic means in melanoma cells.
DISCUSSION
In this study, we set out to catalog transcriptome-wide
changes in melanocytes so as to clarify relevant physiological
programs mobilized by these cells in response to UVR
exposure. We adopted several strategic modifications com-
pared with the previously published lower density microarray
studies (Jean et al., 2001; Valery et al., 2001). First,
microarrays obviously exhibit great variability in design and
density. We wanted a microarray with the greatest level of
empirical testing. Thus, we selected the Affymetrix platform
coupled with the Affymetrix U133 Plus 2.0 gene chip for our
analysis. This represents almost 5- to 60-fold increase in
interrogated species compared to previous UVR analyses
(Jean et al., 2001; Li et al., 2001; Valery et al., 2001; Sesto
et al., 2002). Second, we used a later timepoint of analysis
(24 hours) as early stress responses may elicit differential
effects downstream in different cell types; thus, we biased our
analysis to detect more secondary effectors that may play
melanocyte-specific functional and physiological roles.
Third, rather than pooling melanocytes from different
individuals (i.e. polygenic analysis), we utilized a primary
melanocytes from a single individual (i.e. monogenic
analysis); we then followed the global assessment with
validating quantitative PCR on a subset of bioinformatically
filtered genes using an expanded panel of six independent
primary melanocyte lines. This approach has its own
advantages and disadvantages. Monogenic approaches
may yield a more robust signal-to-noise ratio as other
genetic influences are minimized, for example variations in
Table 2. continued
Fold induction P-value Gene Description
2.43 0.005 TP53I3 Tumor protein p53 inducible protein 3
2.39 0.0057 STS-1 Cbl-interacting protein Sts-1
2.26 0.0022 GDF-15 Growth differentiation factor 15
2.26 0.0022 CDA08
2.23 0.0039 DDB2 Damage-specific DNA binding protein 2, 48 kDa
2.23 0.0036 ATF3 Activating transcription factor 3
2.22 0.0031 PAPLN Papilin, proteoglycan-like sulfated glycoprotein
2.11 0.0056 NYD-SP29 Testis development protein NYD-SP29
2.1 0.0032 CDKN1A Cyclin-dependent kinase inhibitor 1A (p21, CIP1)
2.09 0.0047 CDH26 Cadherin-like 26
2.08 0.0034 CSPG2 Chondroitin sulfate proteoglycan 2 (versican)
2.04 0.0052 PBEF Pre-B-cell colony enhancing factor 1
2.04 0.0038 IER3 Immediate-early response 3
EPH, erythropoeitin-producing hepatocyte receptor; NOP2, nucleolar protein gene 2; RAS, rat sarcoma viral oncogene homologue; UVR, UV radiation.
Table 3. Genes mapped to specific pathways by the
Ingenuity Pathway Software (UVR clusters)
Transcripts Fold change
p53 transcriptional node
CDKN1A (p21CIP) +2.1
FDXR +2.47
TP53I3 +2.43
DKK1 +2.78
GDF15 +2.26
ATF3 +2.23
EPHA2 +4.03
DDB2 +2.23
ADRB2 +2.8
WWOX (interacts with p53) 3.27
Myc transcriptional node
IER3 +2.04
EGR-1 transcriptional node
NR4A1 +4.07
EGFR, epidermal growth factor receptor; EPH, erythropoeitin-producing
hepatocyte receptor; UVR, UV radiation.
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Figure 4. Induction of UVR cluster genes in primary melanocytes. The genes of interest are labeled outside the individual graphs. The uncolored, dark grey,
and light grey boxes represent transcriptional activities clustered around p53, Myc, and Egr-1, respectively. The gray and black bars represent relative levels of
mRNA transcript upon exposure to 35 and 50 mJ/cm2 of UVB, respectively. The X-axis designates six independent primary melanocyte lines: Lanes 1–6
correspond to primary lines 1–6 (NHM1–6) – two unrelated primary melanocyte lines from the Mayo Clinic (NHM-1, NHM-6) that were different than the
microarray line, two unrelated primary melanocyte lines from Dr Marcus Bosenberg (University of Vermont, Burlington, VT; NHM-3, NHM-4), one primary
melanocyte line from Clonetics (Cambrex Bio Science, Walkersville, Inc., MD; NHM-5), and one primary melanocyte line from Cascade Biologics (Portland,
OR; NHM-2). The Y-axis specifies the fold induction relative to unirradiated control. All samples were normalized to endogenous b-glucuronidase (GusB).
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Table 4. Functional classes of differentially expressed genes
Putative function Genes
Fold change
(UVR/control) Molecular structure Location
Neuron/axon development IGSF4 +4.51 Surface receptor Membrane
EPHA2 +4.03 Surface receptor Membrane
UNC5B +3.27 Surface receptor Membrane
ATF3 +2.23 Transcription factor Nucleus
POU3F1 2.35 Transcription factor Nucleus
NLGN1 2.62 Carboxylic ester hydrolase activity Membrane
ANK3 2.62 Surface receptor Golgi
CNTN3 2.86 Surface receptor Membrane
STIM1 2.89 Matrix protein Membrane
ROBO2 3.94 Surface receptor Membrane
CNTN4 6.52 Surface receptor Membrane
Apoptosis NR4A1 +4.07 Steroid receptor Nucleus
UNC5b +3.27 Surface receptor Membrane
FDXR +2.47 Ferrodoxin reductase Mitochondrion
TP53I3 +2.43 Quinone oxidoreductase
GDF15 +2.26 Growth factor Extracellular
PBEF +2.04 Growth factor Extracellular
IER3 +2.04 Surface receptor Membrane
BCAP29 1.69 Surface receptor Endoplasmic reticulum
LAMA2 2.24 Basement membrane protein Basement membrane
WWOX 3.27 Oxidoreductase Mitochondrion
Protein/vesicular transport RAB25 +4.55 GTP binding Cytoplasm
STX7 +3.01 SNARE complex Endosome
RAB40B +1.95 GTP binding Cytoplasm
SCFD2 +1.69
COH1 1.67 Metallopeptidase activity Membrane
LRBA 1.68 Regulates EGFR internalization Membrane
BCAP29 1.69 Surface receptor Endoplasmic reticulum
SEC15L2 2.15 Vesicle fusion with plasma membrane Exocyst
DNA/RNA modification BAT1 +3.83 ATP-dependent RNA helicase Nucleus
BRUNOL4 +3.58 Bell response element RNA binding Nucleus
TCEA3 +2.44 Transcription factor Nucleus
DDB2 +2.23 Nucleotide excision repair Nucleus
MGMT 2.1 DNA methyltransferase Nucleus
HMGN2 2.42 Chromatin restructuring Nucleus
Cell cycle NSUN4 +4.3 NOL1 domain protein Nucleus
ANAPC11 +3.16 Anaphase promoting complex Nucleus
CDKN1A +2.1 Protein kinase inhibitor Nucleus
AURKB 4.77 Protein kinase Nucleus
Metabolism PITPNB +4.06 Phospholipid transfer Cytoplasm
LIPH +2.77 Lipase Extracellular
DPYD 2.99 Dihydroorotate dehydrogenase Intracellular
GMDS 3.28 GDP-mannose 4,6-dehydratase activity Intracellular
Redox regulation; steroid metabolism CYP3A7 +6.52 Cytochrome p450, subfamily 3, peptide 7 Endoplasmic reticulum
CYP3A5 +5.43 Cytochrome p450, subfamily 3, peptide 5 Endoplasmic reticulum
AKR1C4 +3.55 Aldoketo reductase Cytoplasm
FDXR +2.47 Ferrodoxin reductase Mitochondrion
TP53I3 +2.43 Quinone oxidoreductase
Table 4 continued on following page
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pigmentary status, promoter variants that regulate expression,
and varying age of cells. Because these factors likely impact
UVR response to some extent, important signals may be lost
in pooled samples as subsets of melanocytes may respond
differentially and the overall aggregate transcript profile may
not detect significant changes. However, monogenic assess-
ments may fail to identify some transcripts because, as we
have demonstrated, individuals are likely to be differentially
sensitive to UVR.
In our analysis, we focused on the top 100 statistically
most significant gene expression changes modulated by UVR.
Using the Ingenuitys Pathway database, we focused largely
on a cluster of transcriptional activity around p53, a known
UVR-responsive transcription factor in melanocytes (Kade-
karo et al., 2003). The actual levels of p53 mRNA did not
appear to be significantly altered in our microarray analysis
(data not shown). This is consistent with the known UVR-
mediated post-translational stabilization of p53 protein rather
than an effect on p53 transcript levels. Although p53 protein
levels are known to be increased in response to UVR, the
subset of p53 targets in melanocytes that lead to downstream
effector functions are largely unknown. In this study, we have
identified and confirmed a subset of genes regulated by p53
and responsive to UVR in melanocytes. Some previously
undisclosed p53 targets are worthy of mention. The
b-adrenergic receptor, Adrb2, has recently been shown to
be expressed in melanocytes and to play a role in
catecholaminergic control of pigmentation (Gillbro et al.,
2004). Thus, elevation in ADRB2 levels may be a novel UVR-
response to increase intracellular cAMP levels and melano-
genesis. Although the Wnt pathway is known to be critical for
pigment cell development (Dunn et al., 2005), the induction
of dickkopf homolog 1, DKK1, a regulator of Wnt signaling,
directly implicates this signaling stream in the pigment cell’s
response to UVR. Although DKK1 has been shown to be
elevated in response to genotoxic stress (Grotewold and
Ruther, 2002), the loss of DKK1 in many melanoma cell lines
raises the possibility of a more direct role for Dkk1 in
proliferative control. Regulation of intracellular redox states
appears to be a critical as oxidative stress is caused by
UVR (reviewed in Halliday, 2005). Transcriptional changes
occurred in two p53-regulated genes – FDXR and TP53I3 –
and several other genes, such as aldo-keto reductase family 1,
Table 4. continued
Putative function Genes
Fold change
(UVR/control) Molecular structure Location
MSRA 2.34 Methionine sulfoxide reductase Mitochondrion/cytoplasm
WWOX 3.27 Oxidoreductase Mitochondrion
Angiogenesis EPHA2 +4.03 Surface receptor Membrane
AGGF1 +2.57 Secreted angiogenic factor Extracellular
ENPEP 3.76 Glutamyl aminopeptidase Membrane
Transcription factors ONECUT1 +4.39 Nucleus
ZNF-175 +4.12 Nucleus
NR4A1 +4.07 Nucleus
AF5Q31 +3.46 Nucleus
NFIX +3.03 Nucleus
TCEA3 +2.44 Nucleus
ATF3 +2.23 Nucleus
SHOX2 1.75 Nucleus
ZNF291 1.78 Nucleus
POU3F1 2.35 Nucleus
EGFR, epidermal growth factor receptor; EPH, erythropoeitin-producing hepatocyte receptor; NOL1, nucleolar protein 1; SNARE, soluble N-ethylmale-
imide-sensitive factor attachment protein receptor; UVR, UV radiation.
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Figure 5. Relative UVR-induced expression changes of BH family members.
The relative levels of induction by UVR of proapoptotic (Bax, Bad, Bok,
Bid, Bim, Bik, Hrk, Noxa, and Puma) and prosurvival (Bcl-2, Bcl-XL, A1,
Bcl-w, and Mcl-1) members of the BH family are shown in red and blue,
respectively. There is a general trend towards induction of all genes although
individually, these genes did not reach significance at P¼ 0.01. The actual
values are enumerated in Table S1.
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Figure 6. Relative levels of UVR cluster genes in unirradiated primary melanocytes and melanoma cell lines. The genes of interest are again labeled outside
the individual graphs. The uncolored, dark grey, and light grey boxes represent transcriptional activities clustered around p53, Myc, and Egr-1, respectively, as in
Figure 4. The gray bars represent levels of transcript normalized to endogenous b-glucuronidase (GUSB). The X-axis designates four independent primary
melanocyte lines (NHM-3 and 5 (lanes 1, 2) from University of Vermont, NHM-5 (lane 3) from Clonetics, and NHM-6 (lane 4) from Mayo)) and six melanoma
cell lines (UACC903, A375, WM164, SK-Mel-28, WM35, MM-LH in lanes 5–10, respectively) and the Y-axis specifies the relative transcript levels. As an
example, for p21CIP, there was 12 times the amount of p21CIP transcript as GusB in NHM-3 (lane 1) but only 4 times the amount of p21CIP compared to GusB
in melanoma cell line A375 (lane 6). As in Northern blotting, assuming GusB levels to be similar between the two lines, p21CIP can then be interpreted to be
expressed at a higher level in NHM-3 relative to A375.
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member C4 (AKR1C4) and methionine sulfoxide reductase A
(MSRA), not known to be targets of p53.
One gene that is consistently downregulated by UVR in
melanocytes is WWOX. This gene has been reported to
interact with p53 and consistently exhibits downregulation by
UVR is WWOX. There is extant evidence that Wwox can
bind both p53 (Chang, 2002) and p73 (Aqeilan et al., 2004b),
although the full functional consequences of this interaction
is still unknown. The WWOX gene is located at the
chromosome 16q23 common fragile site and reported to be
underexpressed in some cancers (Aqeilan et al., 2004a). From
our data, WWOX expression is not significantly diminished
in melanomas as compared to melanocytes.
Other known p53 targets, such as TYR (Khlgatian et al.,
2002) or TYRP1 (Nylander et al., 2000) were not found to
be elevated. This may reflect differences in constitutive
pigmentation or possibly the kinetics of induction. Alterna-
tively, enforced expression of p53 in experimental assays
may lead to transcriptional induction of these genes, but,
in vivo, UVR may in fact regulate these genes in more
complex circuitries.
On the one hand, many prosurvival genes, including IER3
and survival members of the BH family, are induced along
with DNA repair enzymes such as DDB2. On the other hand,
proapoptotic genes, such as TP53I3, ferrodoxin reductase
(FDXR), and apoptotic members of the BH family are also
elevated. The simultaneous expression of these ostensibly
antagonistic processes may in fact result because adjunctive
functions of these genes may not be known and thus
suppositions regarding function are only partially informative.
Alternatively, in any culture system, some cells may be
undergoing apoptosis whereas other cells may be in a
survival/repair mode. In performing a monogenic analysis,
we have attempted to minimize genetic heterogeneity, such
as degree of pigmentation, but other factors, such as position
in the cell cycle, may also play a role in determining
vulnerability to UVR.
As the full function of most human genes is unknown, it is
not yet possible to construct a coherent model capturing all
the relevant physiological activities. However, several func-
tional themes emerge. For instance, a number of genes that
regulate neuronal development, including axonal and synap-
tic guidance (Table 4), appear to be UVR responsive. These
include contactin-3 (CNTN3, also known as BIG1), con-
tactin-4 (CNTN4, also known as BIG2) (Yoshihara et al.,
1994, 1995), Robo2/Slit (Miyasaka et al., 2005), SynCAM (or
IGSF4) (Watabe et al., 2003), EphA2 (Brittis et al., 2002),
Unc5b (Lu et al., 2004), neuroglin-1 (or NLGN1) (Scheiffele
et al., 2000), ankyrin-G (also known as ANK3) (Ango et al.,
2004), and Stim1 (Hansen et al., 2004). Two transcription
factors – Atf3 (Pearson et al., 2003) and Pou3F1 (Jaegle et al.,
1996) – that have also been shown to participate in axonal
outgrowth and neural development were also differentially
expressed. It has long been observed that melanocytes will
form dendrites in response to UVB irradiation often in the
direction of light exposure (Iyengar, 1994; Yamashita et al.,
2005). Thus, UVR may induce trophic factors, such as
endothelin-1 (Hara et al., 1995), that mediate the surface
arborization. As axonal outgrowth and neural patterning
during neural development occurs through spatially restricted
expression of the same molecules, it is possible that
melanocytes coordinate critical developmental genes from
its neuroectodermal lineage in order to regulate dendrite
outgrowth in a targeted orientation.
The redistribution of melanosomes down dendrites with
subsequent transfer to keratinocytes is also a known UVR
response (Gibbs et al., 2000; Virador et al., 2002; Boissy,
2003). The expression of several vesicular transport proteins
were altered including two RAB genes (RAB25 and RAB40B)
and syntaxin-7, a SNARE complex protein. Both Rab
and syntaxin proteins have been previously reported to be
associated with melanosome trafficking (Virador et al., 2002;
Boissy, 2003).
In summary, we used a transcriptome-wide approach to
identify potential genes that participate in the melanocytic
response to UVR. Many of these changes can be assigned to
functional groups that parallel known melanocyte physio-
logy. The identification of select p53 targets confirms a
known role for p53 in the UVR response; more importantly
however, the specific identity of these genes generates new
avenues for investigation in the UVR biology of melanocytes
and possibly melanoma tumorigenesis.
MATERIALS AND METHODS
Source of cells
For the microarray analysis, we obtained NHMs from a single
neonate (Mayo Clinic, Rochester, MN; designated NHM-Mayo)
through an Institutional Review Board-approved protocol at the
Mayo Clinic. Since the discarded tissue was de-identified, informed
consent was not obtained. The work was conducted according to the
Declaration of Helsinki Principles. For validation, six additional lines
were obtained (NHM1–6): two other unrelated primary neonatal
melanocyte lines from the Mayo Clinic (NHM-1, NHM-6), two
unrelated neonatal foreskin melanocyte lines from the University of
Vermont, (NHM-3, NHM-4), one primary neonatal melanocyte
line from Clonetics (Cambrex Bio Science, Walkersville, Inc.,
MD; NHM-5) and one primary neonatal melanocyte line from
Cascade Biologics (Portland, OR; NHM-2). Melanocytes were all
lightly pigmented.
Cells were grown in Medium 154 supplemented with
Human Melanocyte Growth Supplement (Cascade Biologics,
Portland, OR) and penicillin/streptomycin. Melanocytes were
expanded to approximately 20 million cells and 18 hours
before the irradiation, the cells were re-plated at 2.5 million
cells per 150-cm dish. The cultures were subconfluent and
replicating at the time of irradiation. On the morning of UV
irradiation, the cells were washed with phosphate-buffered
saline and checked for attachment and viability. For validation
purposes, additional NHM were purchased from Cascade Biologics
(Portland, OR) and cultured in the same media with the Human
Melanocyte Growth Supplement.
In order to examine the relative levels of gene expression among
primary melanocyte lines and melanoma cell lines, we used
unstimulated primary melanocyte lines NHM-3, NHM-4, NHM-5,
NHM-6 and melanoma cell lines UACC903, A375, WM164, SK-
Mel-28, WM35 and MM-LH (Yang et al., 2005).
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UV irradiation
We subjected the NHMs to UVB/UVA exposure using a bank of
pre-heated 12 fluorescent FS36T12-UVB-HO tubes (Ultralite bulbs,
Ultralite Enterprises, Inc., Lawrenceville, GA) filtered with Kodacel
(Kodak, Rochester, NY) to remove all radiation below 290 nm. The
temperature within the irradiation chamber was kept constant with a
rotating fan. Unirradiated controls were kept from light exposure but
subjected to all other manipulations. The fluence was 0.56 mW/cm2
measured with a Portable High Accuracy UV-Visible Spectro-
radiometer (Optronic Laboratories, Inc., Orlando, FL). The spectral
distribution of our light source is diagrammed in Supplementary
Figure S1. In determining a dose, we wanted to document a clear
cellular response to the UVR without obvious evidence of toxicity.
There was some evidence of growth arrest between 10 and 30 mJ/
cm2 at 24 hours but no evidence of cell death (data not shown). We
thus selected a dose of 25 mJ/cm2, which is in line with other studies
(Lefort et al., 2001; Pedeux et al., 2002; Sesto et al., 2002; Zhang
and Rosdahl, 2003). Immediately after irradiation, cells were washed
with phosphate-buffered saline, re-fed with complete media and
returned to 371C.
Microarray
Total RNA from quadruplicate samples of UV-irradiated (exposed
in pairs to minimize local fluctuations in fluence) and quadruplicate
samples of control unirradiated NHMs (from Mayo Clinic)
were isolated using the Qiagen RNAeasy kit (Valencia, CA) and
then submitted to the Harvard/Partners Center for Genetics
and Genomics Microarray facility for analysis with the Affymetrix
Human Genome U133 Plus 2.0. Chips. This Microarray contains
1,300,000 unique oligonucleotides covering over 47,000 transcripts,
which in turn represent approximately 39,000 of the best-character-
ized human genes. RNA purity was determined initially by 260/
280¼ 1.85–2.01 and finally by scanning with an Agilent 2100
Bioanalyzer using the RNA 6000 Nano LabChips. Total RNA
was subjected to subsequent labeling and hybridization only if the
18S/28S ratio was approximately 2.0 as determined by the
Bioanalyzer.
The steps of cDNA synthesis were carried out using standard
Affymetrix kits, which provided all necessary reagents in one kit
for synthesis of double-stranded cDNA containing the T7 promoter
sequence from 1 to 15 mg of total RNA or 0.2–2mg of mRNA.
Cleanup of cDNA was also carried out using the Affymetrix
cDNA cleanup kits. In vitro transcription and labeling of cRNA
were performed using Affymetrix reagents designed for in vitro
transcription amplification and biotin-labeling to prepare targets
for GeneChips brand arrays. Hybridization was carried out
according to the Affymetrix GeneChips Manual. Twenty micro-
grams of labeled, fragmented in vitro transcription material was the
nominal amount used on the GeneChips arrays. A model 320
hybridization oven was used to incubate the arrays at a constant
temperature of 451C overnight. Preparation of microarrays for
scanning was carried out with Affymetrix wash protocols on a
Model 450 Fluidics station under the control of Affymetrix GeneChip
Operating Software.
Scanning was carried out on an Affymetrix Model 3000 scanner
with an autoloader. We used the Affymetrix GeneChip Operating
Software operating system to control the Model 3000 scanner
data acquisition functions, first-level data analysis and desktop data
management for the entire GeneChip System. Percent present calls
(ranges between 30 and 55%), background (o100), and spike-in
control measurements were made using the GeneChip Operating
Software algorithms and represented the fraction of detected
transcripts out of the total number of transcripts present on the
array. Image scanning and data pre-processing to obtain trans-
cript measurements were performed using Affymetrix MAS
5.0 following the protocol recommended by the manufacturer
(http://www.affymetrix.com).
Analysis
We then used the GeneCluster 2.0. (Golub et al., 1999; Tamayo
et al., 1999) software to assess differences in expression pattern. A
class prediction method was used to select genes most correlated
with UVR exposure. Although these features or ‘‘marker genes’’ are
themselves biologically interesting, they were used as iterative inputs
into a classification algorithm that uses existing ‘‘labeled’’ samples to
build a model to predict the labels for future samples. Genes
correlated with unirradiated and irradiated sets were then directly
identified and selected by using a ‘‘distance’’ metric. The corrected
T-statistic (Golub et al., 1999), as implemented in GeneCluster 2.0
and currently in GenePattern (www.broad.mit.edu), was used to
generate a ranking of ‘‘most suppressed’’ and ‘‘most induced’’ genes
by UVR; when needed, the T-statistic was converted to P-values
using 6 degrees of freedom.
The top 100 ranked UVR-suppressed and top 100 ranked UVR-
induced genes were then subjected to the Ingenuitys Pathway
Analysis (http://www.ingenuity.com/) for identification of interacting
genes and transcription factor nodes.
Quantitative PCR
Selected genes exhibiting differential expression in response to
UVR were validated using quantitative PCR. Primers to assess
the expression of select genes were available as Taqmans Gene
Expression Assays (Applied Biosystems, Foster City, CA). All
target genes were labeled with FAM as the fluorescent reporter
while the endogenous control, GUSB, was labeled with VIC as the
fluorescent reporter.
For validation, we subjected six additional unrelated primary
melanocyte lines to UVR irradiation at two doses – 35 and 50 mJ/
cm2. Twenty-four hours after the UV irradiation, all cells were
washed with phosphate-buffered saline and total RNA was extracted
from irradiated and non-irradiated NHMs using the Qiagen RNAeasy
kit (Valencia, CA). Five micrograms of total RNA were then reverse-
transcribed using SuperScriptTM First-strand Synthesis (Invitrogen
Life Technologies, Carlsbad, CA). For quantitative PCR, 3 ml of the
reverse-transcribed product (diluted 1:8) was then used in a 50 ml
reaction along with 0.25 ml of Taq, 5 ml of a 1:10 dilution of 10
PCR reaction, 4 ml 2.5 mM dNTP (all from TaKara, Fisher Scientific,
Hampton, NH) and 1:20 dilution of the Taqmans Gene Expression
Assay primers. Real-time PCR was performed using the MX4000
(Stratagene, La Jolla, CA) cycling 2 minutes at 501C, 10 minutes at
951C, 1 minute at 60–621C for 40 cycles. Serial dilutions for each
primer set was used to determine efficiency and quantitation of
target gene product relative to endogenous control was obtained
using the Pfaffl equation (Pfaffl, 2001) with Etarget and Eref being
the efficiencies (E¼ 2.0 at 100% efficiency) of the target and
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endogenous control, respectively:
ðE targetÞDCTtargetðnonUVUVÞ
ðE refÞDCTrefðnonUVUVÞ
where Eref and Etarget are the efficiencies of the endogenous control
and target gene, respectively, and CT is the threshold cycle.
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